HTA355 Value Framework to Support Payer Decisions in Hemophilia in Türkiye
Year: 2025
Type: article
Language: en
Topic: Hemophilia Treatment and Research
Authors and affiliations:
raw_author_name: Zsuzsa Reka Pozsar
raw_affiliation_strings: a) Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary b) Center for Pharmacology and Drug Research & Development, Semmelweis University, Budapest, Hungary c) Syreon Research Institute, Budapest, Hungary
raw_author_name: Saadet Koca
raw_affiliation_strings: Ministry of Treasury and Finance, Ankara, Turkey
raw_author_name: Imrahim Yaradiliis
raw_affiliation_strings: Turkish Medicine and Medical Devices Agency, Ankara, Turkey
raw_author_name: Hasan Coskun
raw_affiliation_strings: Turkish Medicine and Medical Devices Agency, Ankara, Turkey
raw_author_name: AYSEGUL GUNBEY OZTEK
raw_affiliation_strings: Social Security Institute (SGK), Ankara, Turkey
raw_author_name: Ugursel Erol
raw_affiliation_strings: Social Security Institute (SGK), Ankara, Turkey
raw_author_name: Olgun SENER
raw_affiliation_strings: Ministry of Health of Republic of Türkiye, Çankaya-Ankara, Turkey
raw_author_name: Sayime Koc
raw_affiliation_strings: Turkish Hemophilia Association, Istanbul, Turkey
raw_author_name: Bulent Zulfikar
raw_affiliation_strings: Turkish Hemophilia Association, Istanbul, Turkey
raw_author_name: Caner Dadak
raw_affiliation_strings: Turkish Hemophilia Association, Istanbul, Turkey
raw_author_name: Haluk Ozsari
raw_affiliation_strings: Value Based Health Association, Istanbul, Turkey
raw_author_name: Zafer Caliskan
raw_affiliation_strings: Value Based Health Association, Istanbul, Turkey
raw_author_name: Huseyin Celik
raw_affiliation_strings: Value Based Health Association, Istanbul, Turkey
raw_author_name: Hakki Gursoz
raw_affiliation_strings: FarmaLojik, Ankara, Turkey
raw_author_name: Ahmet Oğuz Sarıca
raw_affiliation_strings: Presidency of Republic of Türkiye, Ankara, Turkey
raw_author_name: Esra SAFAK. YILMAZ
raw_affiliation_strings: Novo Nordisk, Ankara, Turkey
raw_author_name: Merve Altunba
raw_affiliation_strings: Novo Nordisk, Istanbul, Turkey
raw_author_name: Ceren Simsek
raw_affiliation_strings: Novo Nordisk, Istanbul, Turkey
raw_author_name: KAGAN ATIKELER
raw_affiliation_strings: Sanofi Turkey, Istanbul, Turkey
raw_author_name: Ozgur Pektas
raw_affiliation_strings: Sanofi Turkey, Istanbul, Turkey
raw_author_name: Eray Oktay Yaşasın
raw_affiliation_strings: Sanofi, İstanbul, Turkey
raw_author_name: Guvenc Kockaya
raw_affiliation_strings: ECONIX, Istanbul, Turkey
raw_author_name: Oznur Seyhun
raw_affiliation_strings: ECONIX, Istanbul, Turkey
raw_author_name: Said Al Rashdi
raw_affiliation_strings: a) Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary b) Center for Pharmacology and Drug Research & Development, Semmelweis University, Budapest, Hungary c) Syreon Research Institute, Budapest, Hungary
raw_author_name: Tamas Agh
raw_affiliation_strings: Center for HTA and Pharmacoeconomic Research, University of Pecs & Syreon Research Institute, Budapest, Hungary
raw_author_name: Zoltan Kalo
raw_affiliation_strings: a) Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary b) Center for Pharmacology and Drug Research & Development, Semmelweis University, Budapest, Hungary c) Syreon Research Institute, Budapest, Hungary